Paclitaxel, sold under the brand name Taxol among others, is a chemotherapy medication used to treat ovarian cancer, esophageal cancer, breast cancer, lung cancer, Kaposi's sarcoma, cervical cancer, and pancreatic cancer. It is administered by intravenous injection. There is also an albumin-bound formulation.
Gertrude "Trudy"Belle Elion was an American biochemist and pharmacologist, who shared the 1988 Nobel Prize in Physiology or Medicine with George H. Hitchings and Sir James Black for their use of innovative methods of rational drug design for the development of new drugs. This new method focused on understanding the target of the drug rather than simply using trial-and-error. Her work led to the creation of the anti-retroviral drug AZT, which was the first drug widely used against AIDS. Her well known works also include the development of the first immunosuppressive drug, azathioprine, used to fight rejection in organ transplants, and the first successful antiviral drug, acyclovir (ACV), used in the treatment of herpes infection.
George Herbert Hitchings was an American medical doctor who shared the 1988 Nobel Prize in Physiology or Medicine with Sir James Black and Gertrude Elion "for their discoveries of important principles for drug treatment", Hitchings specifically for his work on chemotherapy.
James Edward Rothman is an American biochemist. He is the Fergus F. Wallace Professor of Biomedical Sciences at Yale University, the Chairman of the Department of Cell Biology at Yale School of Medicine, and the Director of the Nanobiology Institute at the Yale West Campus. Rothman also concurrently serves as adjunct professor of physiology and cellular biophysics at Columbia University and a research professor at the UCL Queen Square Institute of Neurology, University College London.
Kyriacos Costa Nicolaou is a Cypriot-American chemist known for his research in the area of natural products total synthesis. He is currently Harry C. and Olga K. Wiess Professor of Chemistry at Rice University, having previously held academic positions at The Scripps Research Institute/UC San Diego and the University of Pennsylvania.
The Charles F. Kettering Prize was a US$250,000 award given by the General Motors Cancer Research Foundation for the most outstanding recent contribution to the diagnosis or treatment of cancer.
Research Triangle Institute, trading as RTI International, is a nonprofit organization headquartered in the Research Triangle Park in North Carolina, USA. RTI provides research and technical services. It was founded in 1958 with $500,000 in funding from local businesses and the three North Carolina universities that form the Research Triangle. RTI research has covered topics like HIV/AIDS, healthcare, education curriculum and the environment. The US Agency for International Development accounts for about 35 percent of RTI's research revenue.
Samuel J. Danishefsky is an American chemist working as a professor at both Columbia University and the Memorial Sloan-Kettering Cancer Center in New York City.
Richard Bruce Silverman is the Patrick G. Ryan/Aon Professor of Chemistry at Northwestern University. His group's main focus is basic and translational research into central nervous system disorders and cancer. He is known for the discovery of pregabalin, which is marketed by Pfizer under the brand name Lyrica.
Charon Robin Ganellin FRS is a British medicinal chemist, and Emeritus Smith Kline and French Professor of Medicinal Chemistry, at University College London.
Monroe Eliot Wall was an American chemist, who co-discovered, with Mansukh C. Wani, paclitaxel and camptothecin, two anti-cancer drugs considered standard in the treatment to fight ovarian, breast, lung and colon cancers. On May 27, 1987, Wall received an honorary doctorate from the faculty of pharmacy at Uppsala University, Sweden.
Charles Heidelberger was a cancer researcher who developed and patented an anticancer drug called 5-Fluorouracil that remains widely used against cancers of the stomach, colon and breast. He was also director of basic research at the University of Southern California's Comprehensive Cancer Center. He received an American Cancer Society National Award in 1974. Heidelberger served on editorial boards of various scientific journals: Cancer Research, Molecular Pharmacology, Biochemical Pharmacology, the International Journal of Cancer, In Vitro, and the Journal of Medicinal Chemistry. He served as director for Basic Research of the USC Cancer Center, and was a Distinguished Professor at the University of Southern California. His former home in Madison, Wisconsin, now known as the Dr. Charles and Judith Heidelberger House, is listed on the National Register of Historic Places.
Dr. Joseph Fried was a Polish-American organic chemist, member of the National Academy of Sciences and the American Academy of Arts and Sciences. He held 200 patents on chemical compounds, with 43 listing him as the sole holder. He was a professor of chemistry and biochemistry at the University of Chicago. Fried discovered fluorohydrocortisone, a chemical used to treat adrenal disorders. He was also director of the organic chemistry at the Squibb Institute. His discoveries were instrumental to the creation of medications to treat inflammatory disorders including as arthritis, psoriasis, and various skin allergies. National Academies Press called him "an outstanding organic chemist who made very special contributions to the field of medicine". Professor Elias James Corey had this to say of Fried: "He was an outstanding, highly creative scientist who straddled both the worlds of pharmaceutical research and academic science. He was one of my heroes, and I've always thought of him as a model scientist of great character and great human warmth."
Sir Shankar Balasubramanian is an Indian-born British chemist and Herchel Smith Professor of Medicinal Chemistry in the Department of Chemistry at the University of Cambridge, Senior Group Leader at the Cancer Research UK Cambridge Institute and Fellow of Trinity College, Cambridge. He is recognised for his contributions in the field of nucleic acids. He is scientific founder of Solexa and biomodal.
Susan Band Horwitz is an American biochemist and professor at the Albert Einstein College of Medicine where she holds the Falkenstein chair in Cancer Research as well as co-chair of the department of Molecular Pharmacology.
Nathanael S. Gray is an American chemist. He serves as Krishnan-Shah Family Professor of chemical and systems biology at Stanford University and director of cancer therapeutics programme at Stanford University School of Medicine. Previously he was a Nancy Lurie Marks Professor of biological chemistry and molecular pharmacology at Harvard Medical School and professor of cancer biology at Dana–Farber Cancer Institute. Gray is also co-founder, science advisory board member (SAB) and equity holder in C4 Therapeutics, Gatekeeper, Syros, Petra, B2S, Aduro, Jengu, Allorion, Inception Therapeutics, and Soltego. C4 Therapeutics, which offered IPO in 2020, was founded based on the ground-breaking research of Jay Bradner, current president of Novartis Institutes for BioMedical Research (NIBR), and of Nathanael S. Gray, while he was professor at Harvard Medical School. Before moving to Stanford University, Nathanael S. Gray created Center for Protein Degradation at Harvard Medical School with $80 million agreement with Deerfield Management venture capital firm. In 2020, Gray Lab permanently moved to Stanford University, that was stated by Stuart Schreiber, co-founder of Broad Institute as "Stanford's huge gain".
Mary Locke Petermann was an American cellular biochemist known for her key role in the discovery and characterization of animal ribosomes, the molecular complexes that carry out protein synthesis. She was the first woman to become a full professor at Cornell University's medical school.
Wendy B. Young is a medicinal chemist and pharmaceutical executive currently employed at Genentech.
Sir William Alexander Denny is a New Zealand medicinal chemist, noted for his work investigating drugs for the treatment of cancer.
